AGC Biologics plots roughly 100 layoffs as CDMO industry's post-COVID hangover persists
AGC Biologics plots roughly 100 layoffs as CDMO industry's post-COVID hangover persists fkansteiner Fri, 05/10/2024 - 11:09
AGC Biologics plots roughly 100 layoffs as CDMO industry's post-COVID hangover persists fkansteiner Fri, 05/10/2024 - 11:09
House's updated biosecurity bill sets 2032 decoupling deadline for industry's work with WuXi AppTec, WuXi Biologics aliu Fri, 05/10/2024 - 10:55
Sanofi keeps Novavax afloat with $1.2B bet on its vaccine platform kdunleavy Fri, 05/10/2024 - 10:54
Fierce Pharma Asia—Takeda restructures; Lilly, Innovent tout GLP-1 win; BIO warns of decoupling damage aliu Thu, 05/09/2024 - 17:55
Argenx shrugs off myasthenia gravis threat from UCB as Vyvgart nears next potential launch fkansteiner Thu, 05/09/2024 - 16:40
Pfizer puts 74 Swiss jobs on chopping block as it folds Seagen into its cancer operations fkansteiner Thu, 05/09/2024 - 11:36
As Vyvanse generics bite, Takeda sets out on $900M restructuring plan zbecker Thu, 05/09/2024 - 11:28
In gene therapy race, bluebird leads Vertex in activating treatment centers but trails in patient starts kdunleavy Thu, 05/09/2024 - 11:15
Merck's Keytruda plus chemo comes up short as post-surgery therapy in newly diagnosed endometrial cancer fkansteiner Thu, 05/09/2024 - 10:45
US gene therapy approvals create a big problem for Brazil. Regulators have to come together, FDA's Peter Marks says aarmstrong Thu, 05/09/2024 - 10:17